Good Reads #2: Industry 4.0 and South Korea as the main powerhouse of biosimilars

Pharma cold chain logistics is very complex with many stakeholders involved. We all work hard to ensure that pharmaceuticals maintain optimal quality all the way to the patients. At Envirotainer we believe that the best way to reach our common goal is to improve collaboration and mutual understanding across the logistics chain, we call it our eco-system thinking. Here, we share articles with our network that we think could benefit us all.

This week’s Good Reads covers two trends in the pharmaceutical industry – Industry 4.0 and the fact that South Korea has started pumping out enormous volumes of biosimilars (cheaper versions of biopharmaceuticals with expired patents).